A single NGS-based solution for (CHO) clone selection and comprehensive characterization of transgene integrity, clonality and stability for cell line development
Thursday 20 May 2021 - 4 PM CET / 10 AM ET
Cergentis' Targeted Locus Amplification (TLA) is regarded as a complete genetic characterization tool throughout the whole cell line development process. TLA has been widely implemented as the primary tool for evaluation of genetic stability and genetic integrity of transgenes and their integration sites.
This webinar will cover the latest updates and developments in our offering and how we support leading pharma in clone selection, MCB characterization and assessing genetic stability of GMP-grade lines.
During the webinar, we will discuss:
- Overview of Cergentis' TLA technology and its deliverables
- Challenges and critical QC steps during (CHO) cell line development
- TLA applications for clone selection and MCB characterization
- Assessment of monoclonality and genetic stability for regulatory filing using TLA
The webinar will be concluded with a live Q&A.
Natalia Loaiza, MSc, PhD Candidate
Sales & Account Manager, Cell Line Development
Bad timing? Sign up to receive the recording afterwards.